Advanced Wound Care World Market 2014-2024
 

Advanced Wound Care World Market 2014-2024

on

  • 1,946 views

For an Executive Summary of this report please contact ediz.ibrahim@visiongain.com (+44 (0)20 7549 9976) or refer to our website ...

For an Executive Summary of this report please contact ediz.ibrahim@visiongain.com (+44 (0)20 7549 9976) or refer to our website http://www.visiongain.com/Report/1198/Advanced-Wound-Care-World-Market-Forecast-2014-2024

Statistics

Views

Total Views
1,946
Views on SlideShare
1,946
Embed Views
0

Actions

Likes
0
Downloads
57
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Advanced Wound Care World Market 2014-2024 Advanced Wound Care World Market 2014-2024 Document Transcript

  • Advanced Wound Care: World Market Forecast 2014-2024 & Future Prospects for Leading Companies ©notice This material is copyright by visiongain. It is against the law to reproduce any of this material without the prior written agreement of visiongain. You cannot photocopy, fax, download to database or duplicate in any other way any of the material contained in this report. Each purchase and single copy is for personal use only.
  • Contents 1. Executive Summary 1.1 Market Highlights 1.2 Overview of the Report Content 1.3 Research and Analysis Methods 1.4 Glossary of Terms Related to Advanced Wound Care 2. An Introduction to Wounds and Wound Care 2.1 Wound: A Concise Definition 2.2 Wounds: Healing-Based Classification 2.2.1 Acute Wounds 2.2.2 Chronic Wounds 2.2.2.1 The Rising Prevalence of Chronic Wounds 2.2.3 Burns 2.3 An introduction to the Skin 2.4 The Phases of Wound Healing 2.4.1 The inflammatory Phase of Wound Healing 2.4.2 The Proliferation Phase of Wound Healing 2.4.3 The Fibroblastic Phase of Wound Healing 2.4.4 The Maturation Phase of Wound Healing 2.5 Wound Care 2.5.1 The Role of Wound Dressing 2.5.2 Wound Care: A Journey through History 2.6 Classification of Wound Care Therapies 2.6.1 Traditional Wound Care 2.6.1.1 Composite Dressings 2.6.1.2 Absorptive Dressings 2.6.1.3 Gauze Dressings 2.6.1.4 Contact Layers www.visiongain.com
  • Contents 2.6.1.5 Compression Therapy 2.6.2 Advanced Wound Care 2.6.2.1 Moist Wound Care 2.6.2.1.1 Hydrocolloid Dressings 2.6.2.1.2 Foam Dressings 2.6.2.1.3 Alginate Dressings 2.6.2.1.4 Hydrogel Dressings 2.6.2.2 Wound Care Devices 2.6.2.2.1 Ultrasound for Wound Therapy 2.6.2.2.2 Negative Pressure Wound Therapy (NPWT) 2.6.2.3 Wound Care Biologics 2.6.2.3.1 Cell Based Therapies 2.6.2.3.2 Skin Replacement Therapies 2.6.2.3.3 Collagen Based Therapies 2.7 Regulation of Medical Devices 2.7.1 The US Approval and Regulation System 2.7.2 The EU Approval and Regulation System 2.7.2.1 Post-marketing Surveillance in the EU 3. The Global Advanced Wound Care Market 2014-2024 3.1 The Global Medical Device Market in 2012 and 2013 3.2 Wound Care: Global Market Overview, 2012 and 2013 3.2.1 Global Wound Care Market Trends 3.3 The Advanced Wound Care Market in 2012 and 2013 3.3.1 Advanced Wound Care: Market Forecast 2014-2024 3.4 Changing Market Shares by Sector, 2014-2024 www.visiongain.com
  • Contents 4. Moist Wound Care Market 2014-2024 4.1 Moist Wound Care: Global Market Overview, 2012 and 2013 4.1.1 Moist Wound Care: Market Forecast 2014-2024 4.2 Moist Wound Care Market Breakdown 4.2.1 Hydrocolloid Dressings: Analysis and Forecast, 2014-2024 4.2.2 Foam Dressings: Analysis and Forecast, 2014-2024 4.2.3 Alginate Dressings: Analysis and Forecast, 2014-2024 4.2.4 Hydrogel Dressings: Analysis and Forecast, 2014-2024 4.2.5 Other Moist Wound Care Products: Analysis and Forecast, 2014-2024 4.3 Moist Wound Care: Pipeline Products, 2014 4.3.1 NanoDOX: A Topical Gel 4.3.2. ‘1’ Primary Wound Dressing: A Cell-Proliferating Spray 4.4 SWOT Analysis of the Moist Wound Care Market, 2014-2024 4.4.1 Strengths 4.4.1.1 Greater Effectiveness Compared with Traditional Wound Care 4.4.1.2 Large Range of Available Products 4.4.2 Weaknesses 4.4.2.1 A Diminishing R&D Pipeline 4.4.2.2 Questionable Effectiveness in Comparison to Some Devices and Biologics 4.4.3 Opportunities 4.4.3.1 More Affordable Compared to Wound Care Devices and Biologics 4.4.3.2 Increasing Prevalence of Chronic Wounds 4.4.4 Threats 4.4.4.1 The Threat of Emerging Technologies 4.4.4.2 Decreasing R&D Funding will Impact on Innovation 5. Wound Care Devices Market 2014-2024 5.1 Wound Care Devices: Global Market Overview, 2012 and 2013 www.visiongain.com
  • Contents 5.1.1 Wound Care Devices Market Forecast 2014-2024 5.2 Wound Care Devices Market Breakdown 5.2.1 NPWT: Largest Segment of the Wound Care Devices Market 5.2.1.1 NPWT Market: Leading Products 5.2.1.2 V.A.C. Therapy 5.2.1.3 RENASYS Systems 5.2.1.4 Other NPWT Systems 5.2.1.5 NPWT Market: Analysis and Forecast, 2014-2024 5.2.2 Ultrasound Wound Therapy 5.2.2.1 Ultrasound Wound Therapy: Leading Products 5.2.2.2 Ultrasound Wound Therapy Market: Analysis and Forecast, 2014-2024 5.2.3 Other Wound Care Devices 5.2.3.1 Electrical Stimulation 5.3 Wound Care Devices: Pipeline Products, 2014 5.3.1 dermaPACE, Sanuwave Health 5.3.2 O-ACE-Sys, Ingenious Technologies Corporation 5.3.3 Red Light Wave Therapy, Lightwave Technologies 5.4 SWOT Analysis of the Wound Care Devices Market, 2014-2024 5.4.1 Strengths 5.4.1.1 Continuous Innovation and a Strong R&D pipeline 5.4.1.2 Higher Effectiveness Compared with Other Treatments 5.4.2 Weaknesses 5.4.2.1 The Dominance of Negative Pressure Wound Therapy 5.4.2.2 An Oligopolistic Market 5.4.3 Opportunities 5.4.3.1 Decreasing Prices will Drive Market Growth 5.4.3.2 Increasing Prevalence of Chronic Wounds 5.4.4 Threats 5.4.4.1 Litigation: A Threat to Innovation www.visiongain.com
  • Contents 6. Wound Care Biologics Market 2014-2024 6.1 Wound Care Biologics: Global Market Overview, 2012 and 2013 6.1.1 Wound Care Biologics Market Forecast 2014-2024 6.2 Wound Care Biologics Market Breakdown 6.2.1 Skin Replacement Therapies: High Growth Potential 6.2.1.1 Skin Replacement Therapies Market: Leading Products 6.2.1.1.1 Apligraf, Organogenesis 6.2.1.1.2 Dermagraft, Organogenesis (Formerly of Shire Regenerative Medicine) 6.2.1.1.3 Other Skin Replacement Therapies 6.2.1.2 Skin Replacement Therapies Market: Pipeline Products, 2014 6.2.1.3 Skin Replacement Therapies: Analysis and Forecast, 2014-2024 6.2.2 Collagen Based Therapies 6.2.2.1 Collagen Based Therapies: Leading Products 6.2.2.2 Collagen Based Therapies: Analysis and Forecast, 2014-2024 6.2.3 Cell Therapies 6.2.3.1 Cell Therapies Market: Leading Products 6.2.3.2 Cell Therapies: Analysis and Forecast, 2014-2024 6.2.4 Other Wound Care Biologics 6.3 Wound Care Biologics: Pipeline Products, 2014 6.3.1 Stem Cells 6.3.1.1 Stem Cell Skin Gun, Mc Gowan Institute for Regenerative Medicine: University of Pittsburgh 6.3.1.2 Mesenchymal Stem Cells: Nara University, Japan 6.3.2 Nanotechnology 6.3.2.1 Phytochemical Tissue Bonding: Harvard University Institute of Photomedicine 6.3.2.2 DermaFuse: Missouri S&T and Mo-Sci Corporation 6.3.3 Artificial Skin www.visiongain.com
  • Contents 6.3.3.1 ReCell: Avita Medical 6.3.3.2 e-Skin: UC Berkeley 6.3.3.3 Automated Artificial Skin Production: Fraunhofer Institute 6.3.4 Collagen Based Wound Therapy: Cornell University 6.4 SWOT Analysis of the Wound Care Biologics Market, 2014-2024 6.4.1 Strengths 6.4.1.1 Fresh Innovations Producing New Technologies 6.4.1.2 Greater Effectiveness of Biologics 6.4.1.3 Rich R&D Pipeline: A Driver for Market Growth 6.4.2 Weaknesses 6.4.2.1 Barriers to Entry: High 6.4.2.2 The Dominance of Small Biotech Companies 6.4.2.3 The Price of Biologics: A Potential Restraint to Reimbursement 6.4.3 Opportunities 6.4.3.1 The Prospect of Diagnostic Testing 6.4.3.2 Rising Prevalence of Chronic Wounds 6.4.3.3 Stem Cells: Possibility for the Treatment of Multiple Indications 6.4.4 Threats 6.4.4.1 The Competition from Moist Wound Care and Devices 6.4.4.2 High Barrier to Entry: A Strong Deterrent 7. Leading National Advanced Wound Care Markets 2014-2024 7.1 The Advanced Wound Care Market by Regional Sales 7.1.1 The Global Distribution of Advanced Wound Care in 2012 and 2013 7.2 Leading National Markets: Forecast, 2014-2024 7.2.1 Changing Market Shares by Region, 2014-2024 7.3 Regional Advanced Wound Care Markets: Analysis and Forecasts, 2014-2024 7.3.1 United States: A Tale of Taxes and Changing Reimbursement Models 7.3.2 The EU5 Markets: Europe’s Leading AWC Markets www.visiongain.com
  • Contents 7.3.2.1 EU5: Changing Market Shares by Country, 2014-2024 7.3.2.2 Germany: Europe’s Largest Advanced Wound Care Market 7.3.2.3 France: Cumbersome Approval Process Slowing Growth 7.3.2.4 UK: Hospital Inpatients Raising Wound Care Needs 7.3.2.5 Spain: Rationalisation of Healthcare Expenditure Impacting Sales 7.3.2.6 Italy: Gloom Outlook Compounded by Dropping Credit Ratings 7.3.3 Japan: An Aging Population Putting a Strain on Healthcare Budgets 7.3.4 The BRIC Nations 7.3.4.1 China: High Unmet Needs and Expanding Healthcare Coverage will Drive Growth 7.3.4.2 India: High Domestic Growth and a Rapidly Expanding Economy 7.3.4.3 Russia: Irregularities in Legislations Hindering Growth 7.3.4.4 Brazil: Expanding Waistlines and Diabetic Population 7.3.5 South Korea: A Highly Attractive Market to Multinationals 8. Leading Companies in the Advanced Wound Care Market 2014 8.1 Kinetic Concept Inc: Global Market Leader 8.1.1 NPWT: A Major Market for KCI 8.1.2 VAC Therapy (NPWT): A Success Story 8.1.3 Systagenix and Kinetic Concept Merger 8.2 Smith & Nephew 8.2.1 S&N’s Advanced Wound Management 8.3 Molnlycke Healthcare 8.3.1 Molnlycke’s Advanced Wound Care Product Range 8.3.2 Molnlycke: Revenue Analysis, 2012 and 2013 8.4 ConvaTec 8.4.1 ConvaTec Revenue Analysis, 2012 and 2013 8.4.2 Wound Therapeutics: A Golden Goose for ConvaTec 8.5 3M www.visiongain.com
  • Contents 8.5.1 3M: Skin & Wound Care 8.5.2 3M Healthcare Revenue Analysis, 2012 and 2013 8.6 Coloplast 8.6.1 Coloplast’s European Orientation 9. Expert Opinions 9.1 Interview with Mr. Nissim Mashiach, President and Chief Executive Officer, MacroCure 9.1.1 On the Current State of the Advanced Wound Care Market 9.1.2 On the Fate of the Moist Wound Care Sector 9.1.3 MacroCure’s Place in the Advanced Wound Care Market 9.1.4 On the Company’s Growth Strategy and European Expansion 9.1.5 The Multi-Faceted Nature of Wound Care and Wound Healing 9.1.6 On the Challenges Facing the Advanced Wound Care Market 9.1.7 Possible Use of Advanced Wound Care Therapies for Other Indications 9.1.8 Views on the Future Prospects of the Market 10. Conclusions 10.1 Market Overview 10.2 Wound Care Devices and Biologics Set for Rapid Sales Boost 10.3 Rising Prevalence of Chronic Wounds: A Driver for Growth 10.4 Emerging Markets will help in Driving Growth 10.5 Moist Wound Care: Market Summary 10.6 Wound Care Devices: Market Summary 10.7 Wound Care Biologics: Market Summary www.visiongain.com
  • Contents List of Tables Table 2.1 Burn Assessment: The ‘Rule of Nine’ Total Body Classification System (%) Table 2.2 The Classification of Burns by Depth: Degree Classification System Table 2.3 The Classification of Burns by Severity Table 2.4 Advanced Wound Care: Sectors and Descriptions, 2014 Table 2.5 Advantages and Disadvantages of Moist Wound Care Table 2.6 Advantages and Disadvantages of Skin Replacement Therapy Table 2.7 Skin Graft Types and their Descriptions Table 3.1 The Medical Devices Market: Revenues ($bn) and Market Shares (%) by Sector, 2012 Table 3.2 Global Wound Care Market: Revenue ($bn) and Market Share (%) by Sector, 2012 Table 3.3 The Advanced Wound Care Market: Revenues ($bn), Market Shares (%) and Growth (%) by Sector, 2012 and 2013 Table 3.4 The Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%) by Sector, 2012-2024 Table 3.5 Advanced Wound Care Market Forecast: CAGR (%) by Sector, 2013-2018, 2018-2024, and 2013-2024 Table 3.6 The Advanced Wound Care Market: Revenue ($bn) by Sector, 2012, 2018, 2024 Table 3.7 The Advanced Wound Care Market: Market Share (%) by Sector, 2012, 2018, 2024 Table 3.8 The Advanced Wound Care Market: Drivers and Restraints, 2014-2024 Table 4.1 Moist Wound Care Market: Revenues ($bn), Market Shares (%) and Growth (%) by Sector, 2012 and 2013 Table 4.2 The Moist Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%) by Sector, 2012-2024 Table 4.3 Hydrocolloid Dressings Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024 Table 4.4 Foam Dressings Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024 Table 4.5 Alginate Dressings Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024 Table 4.6 Hydrogel Dressings Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024 Table 4.7 Selected Moist Wound Care Products, 2014 Table 4.8 Moist Wound Care Pipeline Products, 2014 www.visiongain.com
  • Contents Table 4.9 SWOT Analysis of the Moist Wound Care Market, 2014-2024 Table 5.1 Wound Care Devices Market: Revenues ($bn), Market Shares (%) and Growth (%) by Sector, 2012 and 2013 Table 5.2 The Wound Care Devices Market: Revenue Forecast ($bn, AGR%, CAGR%) by Sector, 2012-2024 Table 5.3 The Negative Pressure Wound Therapy (NPWT) Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024 Table 5.4 The Negative Pressure Wound Therapy (NPWT) Market: Drivers and Restraints, 20142024 Table 5.5 Ultrasound Wound Therapy: Leading Products, 2014 Table 5.6 The Ultrasound Wound Therapy Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012- 2024 Table 5.7 Electrical Stimulation Devices: Leading Products, 2014 Table 5.8 Wound Care Devices Pipeline Products, 2014 Table 5.9 SWOT Analysis of the Wound Care Devices Market, 2014-2024 Table 6.1 Wound Care Biologics Market: Revenues ($bn), Market Shares (%) and Growth (%) by Sector, 2012 and 2013 Table 6.2 The Wound Care Biologics Market: Revenue Forecast ($m, AGR%, CAGR%) by Sector, 2012-2024 Table 6.3 Wound Care Biologics: Market Drivers and Restraints, 2014-2024 Table 6.4 Skin Replacement Therapies: Leading Products, 2014 Table 6.5 The Skin Replacement Therapies Market: Revenue Forecast ($m, AGR%, CAGR%), 2012- 2024 Table 6.6 Collagen Based Therapies: Leading Products, 2014 Table 6.7 The Collagen Based Therapies Market: Revenue Forecast ($m, AGR%, CAGR%), 20122024 Table 6.8 Cell Therapies: Leading Products, 2014 Table 6.9 The Cell Therapies Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024 Table 6.10 Other Wound Care Biologics Therapies, 2014 Table 6.11 Wound Care Biologics Pipeline Products, 2014 Table 6.12 SWOT Analysis of the Wound Care Devices Market, 2014-2024 www.visiongain.com
  • Contents Table 7.1 The Advanced Wound Care Market: Revenues ($bn) and Growth (%) by Region, 2012 and 2013 Table 7.2 The Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%) by Region, 2012-2024 Table 7.3 Advanced Wound Care Market Forecast: CAGR (%) by Region, 2013-2018, 20182024, and 2012-2024 Table 7.4 The Advanced Wound Care Market: Market Shares (%) by Region, 2012, 2018, 2024 Table 7.5 The US Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2012-2024 Table 7.6 US Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%), 20122024 Table 7.7 The EU5 Advanced Wound Care Market Forecast: Market Size ($bn), Market Share (%) and CAGR (%), 2012-2024 Table 7.8 The EU5 Advanced Wound Care Market: Revenues ($bn) and Growth (%) by Region, 2012 and 2013 Table 7.9 The EU5 Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%) by Country, 2012-2024 Table 7.10 The EU5 Advanced Wound Care Market: Market Shares (%) by Country, 2012, 2018, 2024 Table 7.11 The German Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2012-2024 Table 7.12 The German Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024 Table 7.13 The French Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2012-2024 Table 7.14 The French Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024 Table 7.15 The UK Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2012-2024 Table 7.16 The UK Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024 www.visiongain.com
  • Contents Table 7.17 The Spanish Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2012-2024 Table 7.18 The Spanish Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024 Table 7.19 The Italian Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2012-2024 Table 7.20 The Italian Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024 Table 7.21 The Japanese Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2012-2024 Table 7.22 The Japanese Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024 Table 7.23 The Chinese Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2012-2024 Table 7.24 The Chinese Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024 Table 7.25 The Indian Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2012-2024 Table 7.26 The Indian Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024 Table 7.27 The Russian Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2012-2024 Table 7.28 The Russian Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024 Table 7.29 The Brazilian Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2012-2024 Table 7.30 The Brazilian Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024 Table 7.31 The South Korean Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2012-2024 Table 7.32 The South Korean Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, www.visiongain.com
  • Contents CAGR%), 2012-2024 Table 8.1 KCI’s VAC Therapies at a Glance, 2014 Table 8.2 Smith & Nephew: Historical Revenue ($bn, AGR %), 2008-2012 Table 8.3 Smith & Nephew: Revenue by Segment ($bn), 2012 Table 8.4 Smith & Nephew Advanced Wound Management: Revenue ($bn) and Revenue Share (%) by Segment, 2012 Table 8.5 Smith & Nephew Advanced Wound Management: Revenue ($bn) and Revenue Share (%) by Region, 2012 Table 8.6 Molnlycke Advanced Wound Care Products and Description, 2014 Table 8.7 Molnlycke: Historical Revenue ($bn, AGR %), 2008-2012 Table 8.8 ConvaTec’s Wound Therapeutics Products and Description, 2014 Table 8.9 ConvaTec: Revenue ($m) and Revenue Share (%) by Segment, 2012 Table 8.10 ConvaTec: Historical Wound Therapeutics Revenue ($m, AGR %), 2009-2012 Table 8.11 3M: Revenue ($m) and Revenue Shares (%) by Franchise, 2012 Table 8.12 3M: Tegaderm Wound Care Products and Description, 2014 Table 8.13 3M: Historical Healthcare Revenue ($bn, AGR %), 2008-2012 Table 8.14 Coloplast: Revenue ($m) and Revenue Share (%) by Segment, 2013 Table 8.15 Coloplast: Revenue ($m) and Revenue Growth (%) by Region, 2012, 2013 Table 10.1 Projected Advanced Wound Care Market Size ($bn, CAGR%): 2012, 2017, 2020, 2024 Table 10.2 The Global Advanced Wound Care Market: Revenue ($bn) by Sector, 2012, 2017, 2020, 2024 Table 10.3 The Global Advanced Wound Care Market: Market Share (%) by Sector, 2012, 2017, 2020, 2024 List of Figures Figure 2.1 Wound Healing Phases and Duration (Days) Figure 2.2 Functions of Wound Dressing Figure 3.1 The Medical Device Market: Revenue (£bn) by Sector, 2012 www.visiongain.com
  • Contents Figure 3.2 The Medical Device Market: Market Shares (%) by Sector, 2012 Figure 3.3 Global Wound Care Market: Revenue ($bn) by Sector, 2012 Figure 3.4 Global Wound Care Market: Market Share (%) by Sector, 2012 Figure 3.5 The Advanced Wound Care Market: Revenues ($bn) by Sector, 2012 and 2013 Figure 3.6 The Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024 Figure 3.7 Advanced Wound Care Market Forecast: CAGR (%) by Sector, 2013-2018 Figure 3.8 Advanced Wound Care Market Forecast: CAGR (%) by Sector, 2018-2024 Figure 3.9 Advanced Wound Care Market Forecast: CAGR (%) by Sector, 2013--2024 Figure 3.10 The Advanced Wound Care Market: Revenue ($bn) by Sector, 2012, 2018, 2024 Figure 3.11 The Advanced Wound Care Market: Market Share (%) by Sector, 2012 Figure 3.12 The Advanced Wound Care Market: Market Share (%) by Sector, 2018 Figure 3.13 The Advanced Wound Care Market: Market Share (%) by Sector, 2024 Figure 4.1 Moist Wound Care Market: Revenue ($bn) by Sector, 2012 Figure 4.2 Moist Wound Care Market: Market Share (%) by Sector, 2012 Figure 4.3 The Moist Wound Care Market: Revenue Forecast ($bn), 2012-2024 Figure 4.4 Hydrocolloid Dressings Market: Revenue Forecast ($bn), 2012-2024 Figure 4.5 Foam Dressings Market: Revenue Forecast ($bn), 2012-2024 Figure 4.6 Alginate Dressings Market: Revenue Forecast ($bn), 2012-2024 Figure 4.7 Hydrogel Dressings Market: Revenue Forecast ($bn), 2012-2024 Figure 5.1 Wound Care Devices Market: Revenue ($bn) by Sector, 2012, 2013 Figure 5.2 Wound Care Devices Market: Market Share (%) by Sector, 2012 Figure 5.3 The Wound Care Devices Market: Revenue Forecast ($bn), 2013-2024 Figure 5.4 The Negative Pressure Wound Therapy (NPWT) Market: Revenue Forecast ($bn), 2012-2024 Figure 5.5 The Ultrasound Wound Therapy Market: Revenue Forecast ($bn), 2012-2024 Figure 6.1 Wound Care Biologics Market: Revenue ($bn) by Sector, 2012, 2013 Figure 6.2 Wound Care biologics Market: Market Share (%) by Sector, 2012 Figure 6.3 The Wound Care Biologics Market: Revenue Forecast ($m), 2012-2024 Figure 6.4 The Skin Replacement Therapies Market: Revenue Forecast ($m), 2012-2024 Figure 6.5 The Collagen Based Therapies Market: Revenue Forecast ($m), 2012-2024 Figure 6.6 The Cell Therapies Market: Revenue Forecast ($m), 2012-2024 www.visiongain.com
  • Contents Figure 7.1 The Advanced Wound Care Market: Revenues ($bn) by Region, 2012 Figure 7.2 US, EU5, Japan, and China Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024 Figure 7.3 Russia, Brazil, and South Korea Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024 Figure 7.4 Advanced Wound Care Market Forecast: CAGR (%) by Region, 2013-2018 Figure 7.5 Advanced Wound Care Market Forecast: CAGR (%) by Region, 2018-2024 Figure 7.6 Advanced Wound Care Market Forecast: CAGR (%) by Region, 2013-2024 Figure 7.7 The Advanced Wound Care Market: Market Shares (%) by Region, 2012 Figure 7.8 The Advanced Wound Care Market: Market Shares (%) by Region, 2018 Figure 7.9 The Advanced Wound Care Market: Market Shares (%) by Region, 2024 Figure 7.10 US Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024 Figure 7.11 The EU5 Advanced Wound Care Market: Revenues ($bn) by Region, 2012 Figure 7.12 Germany, France, UK, Spain, and Italy Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024 Figure 7.13 The EU5 Advanced Wound Care Market: Market Shares (%) by Country, 2012 Figure 7.14 The Advanced Wound Care Market: Market Shares (%) by Country, 2024 Figure 7.15 The German Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024 Figure 7.16 The French Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024 Figure 7.17 The UK Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024 Figure 7.18 The Spanish Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024 Figure 7.19 The Italian Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024 Figure 7.20 The Japanese Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024 Figure 7.21 The Chinese Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024 Figure 7.22 The Indian Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024 Figure 7.23 The Russian Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024 Figure 7.24 The Brazilian Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024 Figure 7.25 The South Korean Advanced Wound Care Market: Revenue Forecast ($bn), 20122024 Figure 8.1 Kinetic Concept Inc: Strengths and Threats, 2014-2024 Figure 8.2 Smith & Nephew: Historical Revenue ($bn), 2008-2012 www.visiongain.com
  • Contents Figure 8.3 Smith & Nephew: Revenue by Segment ($bn), 2012 Figure 8.4 Smith & Nephew: Revenue by Segment (%), 2012 Figure 8.5 Smith & Nephew Advanced Wound Management: Revenue ($bn) by Franchise, 2012 Figure 8.6 Smith & Nephew Advanced Wound Management: Revenue Share (%) by Franchise, 2012 Figure 8.7 Smith & Nephew Advanced Wound Management: Revenue ($bn) by Region, 2012 Figure 8.8 Smith & Nephew Advanced Wound Management: Revenue Share (%) by Region, 2012 Figure 8.9 Molnlycke: Strengths and Threats, 2014-2024 Figure 8.10 Molnlycke: Historical Revenue ($bn), 2008-2012 Figure 8.11 ConvaTec: Revenue ($m) by Segment,, 2012 Figure 8.12 ConvaTec: Revenue Share (%) by Segment,, 2012 Figure 8.13 ConvaTec: Historical Wound Therapeutics Revenue ($m), 2009-2012 Figure 8.14 3M: Revenue Shares (%) by Franchise, 2012 Figure 8.15 3M: Historical Healthcare Revenue ($bn), 2008-2012 Figure 8.16 Coloplast: Revenue ($m) by Segment, 2013 Figure 8.17 Coloplast: Revenue Share (%) by Segment, 2013 Figure 8.18 Coloplast: Revenue ($m) by Region, 2012, 2013 Figure 8.19 Coloplast: Revenue Share (%) by Region, 2013 Figure 10.1 Projected Advanced Wound Care Market Size ($bn): 2012, 2017, 2020, 2024 Figure 10.2 The Global Advanced Wound Care Market: Revenue ($bn) by Sector, 2012, 2017, 2020, 2024 Figure 10.3 Global Over-60 Population: Historical Proportions and Forecast (%), 1950, 2009, 2050 Figure 10.4 The Global Advanced Wound Care Market: Market Share (%) by Sector, 2012, 2017, 2020, 2024 www.visiongain.com
  • Contents Companies Mentioned in this Report 3M Advanced BioHealing (Shire) Advanced Tissue Sciences Anika Therapeutics Avista Capital Partners Avita Medical Biolight AB BlueSky Medical (S&N) Boehringer Ingelheim Brennen Medical Bristol-Myers Squibb BSN Medical Gmbh Celleration Coloplast ConvaTec Covalon Technologies Covidien Derma Sciences Devon Medical Products Dow-Hickman Dr Suwelack Skin & Health Care Garnet Biotherapeutics Genzyme Biosurgery Gerromed GmbH Getinge Forticell Bioscience (formerly Ortec International) Hartmann Group Healo Medical www.visiongain.com
  • Contents Healthpoint Biotherapeutics Hollister Wound Care Human Biosciences Ingenious Technologies Corporation Innocoll Innovative Therapies Integra Life Science Corp Investor AB IYIA Technologies Johnson & Johnson Kaken Pharmaceuticals Kalypto Medical Kinetic Concepts Laboratoires URGO Lescarden Lifecell Lightwave Technologies MacroCure Marine Polymer Technologies Inc Medela Medestea Internazionale Medline Industries MiMedX MiMedX Misonix Molnlycke Mo-Sci Corporation Nanotherapeutics Nordic Capital Partners Organogenesis Osiris Therapeutics www.visiongain.com
  • Contents Politec Saude Polyheal Promethean LifeSciences Prospera Phytoceuticals RedDress Sangui BioTech International Sanuwave Health Shire Regenerative Medicine Smith & Nephew Soring Synapse Microcurrent Systagenix (now part of KCI) Talley Group Vario Vomaris Innovations Wake Forest University Wound Management Technologies Wright Medical www.visiongain.com
  • Contents Organisations Mentioned in this Report Armed Forces Institute of Regenerative Medicine (AFIRM) Center for Disease Control Centers for Medicare and Medicaid Services (CMS) Central Drug Standard Control Organisation (CDSCO) [India] Centre for Devices and Radiological Health (CDRH) Cornell University European Databank on Medical Devices (EUDAMED) Food and Drug Administration (FDA) Fraunhofer Institute Health Insurance Bureau [Japan] Institute of Photomedicine, Harvard University International Diabetic Federation (IDF) International Medical Device Regulators Forum (IMDRF) (formerly GHTF) Italian National Health Service Masachussetts General Hospital (MGH) McGowan Institute for Regenerative Medicine, University of Pittsburgh Ministry of Health & Family Welfare [India] Ministry of Health, Labour and Welfare (MHLW) Ministry of Health, Labour, and Welfare (MHLW) [Japan] Missouri University of Science and Technology Moody’s Investor service Nara University, Japan National Competent Authorities (NCAs) National Health Service (NHS) North Florida/ South Georgia Veterans Health System Pharmaceuticals and Medical Devices Agency (PMDA) [Japan] Roszdravnadzor [Russia] Standard and Poors Rating Services www.visiongain.com
  • Contents The World Bank University of California, Berkeley United Nations (UN) University Hospital Bern Wellman Centre for Photomedicine, Harvard University www.visiongain.com
  • Advanced Wound Care: Market Forecast 2014-2024 & Future Prospects for Leading Companies Table 4.3 Hydrocolloid Dressings Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Hydrocolloid Dressing ($bn) 1.2 AGR (%) CAGR (%) 2013-18 1.3 1.3 1.3 1.4 1.4 1.5 1.6 1.6 1.6 1.6 1.7 1.7 2 3 3 3 4 4 4 1 2 2 1 1 3.4 2018-24 CAGR (%) 2013-24 1.8 2.5 Source: Visiongain 2014 Visiongain forecasts the revenue from hydrocolloid dressings to reach $1.5bn in 2018 (Figure 4.4), growing at a CAGR of 3.4% from 2013. The hydrocolloid dressing market will be driven by increased prevalence of chronic and acute wounds. This market is dominated by multinational companies such as 3M, ConvaTec, Smith &Nephew, and Coloplast who have been in the market for a long while. Controversy regarding the use of hydrocolloid dressings in the treatment of diabetic ulcers may restrain growth in the market during the forecast period. Visiongain predicts slow growth in the hydrocolloid dressing market from 2014 to 2024 with the market growing to $1.7bn in 2024, at a CAGR of 1.8% from 2018 to 2024. 4.2.2 Foam Dressings: Analysis and Forecast, 2014-2024 Foam dressings accounted for 26.5% of the moist wound care market with $1.0bn in global sales. Many foam dressings in the market have been combined with anti-bacterials such as silver to reduce infection and to heal wounds faster. As more innovative combinations reach the market, the benefits of foam dressings will be seen. ALLEVYN (Smith & Nephew), Lyofoam (Molnlycke) and 3M Tegaderm Foam (3M) are some of the leading foam dressings in the market. The versatility and affordability of foam dressings makes them an attractive choice among moist wound care products. Emerging economies will drive growth in the moist wound care market, and visiongain predicts that foam dressings will benefit the most. The foam dressing market will increase to $1.4bn in 2018, with a CAGR of 6.0% between 2013 and 2018. The market will then increase to $1.7bn in 2024, growing at a CAGR of 3.5% between 2018 and 2024 (Table 4.4 and Figure 4.5). www.visiongain.com Page 68
  • Advanced Wound Care: Market Forecast 2014-2024 & Future Prospects for Leading Companies Table 7.32 The South Korean Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 South Korean Market ($bn) AGR (%) 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.4 12 12 12 14 14 15 13 13 11 10 9 8 13.4 CAGR (%) 2013-18 2018-24 10.4 11.8 CAGR (%) 2013-24 Source: Visiongain 2014 Figure 7.25 The South Korean Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024 0.4 0.4 0.3 0.3 0.3 Revenue ($bn) 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.0 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Year Source: Visiongain 2014 www.visiongain.com Page 153
  • Advanced Wound Care: Market Forecast 2014-2024 & Future Prospects for Leading Companies Figure 8.1 Kinetic Concept Inc: Strengths and Threats, 2014-2024 Threats Strengths World leader in NPWT market offering a KCI will likely face strong competition to wide range of products based on its maintain its market position in the NPWT proprietary V.A.C therapy technology. KCI is market. the trusted brand around the world for NPWT products It will have to compete with other established providers of NPWT products as well as KCI is strong in the biologics segment since newer companies introducing several NPWT the acquisition of LifeCell Technologies in devices on the market. 2008. KCI is also constantly growing through expansion into under penetrated markets. The acquisition of Systagenix will help consolidate its possible as market leader in the AWC market Source: Visiongain 2014 Systagenix is based in the UK, and in collaboration with Alere developed WOUNDCHEK Protease status, the world’s first point of care diagnostic test for chronic wounds. The product was launched in January 2012 across Europe, South Africa and the Middle East. Although it has been widely understood that Elevated Protease Activity (EPA) is the key marker in wound healing, it used to be undetected in the past. The Wound Check protease for EPA measurement provides results in 15 minutes enabling the clinician to decide the best treatment for each patient. The product has not yet been approved by the US FDA. KCI decided to expand its operations to Brazil in 2012, following the previous year’s launch of its NPWT systems in the Japanese, Chinese and Indian markets. This will help the company to boost its revenue during the forecast period. The merger between KCI and Systagenix will help to diversify the group’s product portfolio, which will act as a catalyst to stimulate revenue growth for the group (Figure 8.1). www.visiongain.com Page 158